1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Buzón L, Bernardino JI, Galindo Puerto MJ, Martín-Torres J, Alemán Valls MR, Torralba González de Suso M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello Úbeda A, Pedrero-Tomé R, Crusells Canales MJ, Calzado Isbert S, Aguilera García M, Hidalgo Tenorio C, Morano L, Vinuesa García D, de Andrés David C, Bernal Morell E, Martínez Álvarez RM, Cabello Clotet N, Tiraboschi J, Gimeno García A, Vivancos MJ, Troya J.

    Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

    AIDS . : .

    [doi:10.1097/QAD.0000000000004388]

  • Artiles Medina A, Mínguez Ojeda C, Subiela JD, López Curtis D, Domínguez Gutiérrez A, Chamorro Tojeiro S, de la Parra Sánchez I, Jiménez Cidre MÁ, Gómez Dos Santos V, Burgos Revilla FJ.

    A systematic review and meta-analysis evaluating the incidence, microbiological profile and risk factors associated with urinary tract infection after radical cystectomy.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . : .

    [doi:10.1016/j.urolonc.2025.09.027]

  • Alonso Robles AM, Vivancos Gallego MJ, Gorospe Sarasúa L.

    Incidental Finding of a Solitary Sternal Plasmacytoma Detected at Lung Cancer Screening With Low-dose CT in a Smoker With HIV Infection.

    ARCHIVOS DE BRONCONEUMOLOGIA . : .

    [doi:10.1016/j.arbres.2025.10.001]

  • Serrano-Villar S, Martín-Pedraza L, Tiraboschi J, Novella M, Cabello-Úbeda A, López-Cortés L, Busca C, Torralba M, Crusells MJ, Hidalgo-Tenorio C, Estrada V, Del Amo-de Palacios A, Díaz de Santiago A, Fons-Contreras M, Santos J, Bernal E, Montero-Alonso M, Troya J, Blanco JR, Burgos J, de Miguel M, Moreno S.

    Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study).

    CLINICAL INFECTIOUS DISEASES . : .

    [doi:10.1093/cid/ciaf565]

  • Buzón-Martín L, Montes ML, Pedrero R, Galindo MJ, Santacreu-Guerrero M, Alemán MR, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells MJ, Navarro MDC, Aguilera M, Hidalgo-Tenorio C, Morano-Amado LE, Vinuesa D, De Andres C, Bernal-Morell E, Martínez-Álvarez RM, Cabello-Clotet N, Tiraboschi J, Montero MDC, Vivancos-Gallego MJ, Díez C, Calderón R, De Zárraga MA, Gisbert L, Romero-Palacios A, Cabo R, Soler JF, Sepúlveda MA, Sánchez-Guirao AJ, Escrich C, Arnaiz De Las Revillas F, Ferreira E, Valentín B, Lérida A, Llenas-García J, Gómez A, Losa JE, Alonso B, Sanz J, Masiá M, Pernas H, Corte JJ, Garcinuño MÁ, Gainzarain JC, Estébanez M, García-Navarro MDM, Barragán P, Ramos N, Clavero M, Millán M, Del Álamo M, Egido M, De La Calle B, Ferrero OL, Troya J.

    A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

    The Journal of antimicrobial chemotherapy . : .

    [doi:10.1093/jac/dkaf389]

  • Isla D, Zugazagoitia J, Arriola E, García-Campelo R, Martí Blanco C, Diz-Taín MP, López-Brea M, Moreno-Vega AL, León-Mateos L, Oramás J, Gutiérrez-Calderón V, Majem M, Sánchez-Hernández A, Aguado C, Alvarez-Cabellos R, Massutí B, Moreno A, Fírvida-Pérez JL, Valdivia J, González-Cordero M, Zafra-Poves M, Dómine M, Garcia-Navalon FJ, Villanueva N, Provencio M, Juan-Vidal O, Rivas-Corredor C, Olmedo García ME, Palmero R, López-Castro R, Carcereny E, Lechuga JL, Domínguez M, Callejo Á, Paz-Ares L.

    Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial.

    Lung Cancer . 209: 108763-108763.

    [doi:10.1016/j.lungcan.2025.108763]

  • Casado JL, Blanco JL, Izuzquiza I, Moreno A, Vizcarra P, Vallejo A.

    From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV.

    The Journal of antimicrobial chemotherapy . : .

    [doi:10.1093/jac/dkaf357]

  • Casado JL, Vizcarra P, Hernández-Walias FJ, Manuel Del Rey J, Santiuste C, Molano C, Menacho M, Vallejo A.

    Urinary Exosome-Derived microRNAs as Biomarkers of Tenofovir Disoproxil Fumarate (TDF)-Induced Renal Toxicity in People with HIV-1.

    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . : 107654-107654.

    [doi:10.1016/j.ijantimicag.2025.107654]